Synthesis of Congeners and Prodrugs - Mark Cushman

Abstract

Funding Agency

Agency: National Institute of Health (NIH)
Institute: Division of Cancer Treatment (NCI)
Type: Research and Development Contracts (N01)
Project #: N01CM067699-001
Application #: 3614123
Study Section

Project Start: 1986-09-30
Project End: 1991-09-29
Budget Start: 1987-04-28
Budget End: 1988-09-29
Support Year
Fiscal Year: 1987
Total Cost
Indirect Cost

Institution

Name: Purdue University
Department
Type: Schools of Pharmacy
DUNS #: 072051394

City: West Lafayette
State: IN
Country: United States
Zip Code: 47907

Related projects


NIH 1990 N01 CM	Synthesis of Congeners and Prodrugs Cushman, Mark S. / Purdue University
NIH 1989 N01 CM	Synthesis of Congeners and Prodrugs Cushman, Mark S. / Purdue University
NIH 1988 N01 CM	Synthesis of Congeners and Prodrugs Cushman, Mark S. / Purdue University
NIH 1988 N01 CM	Synthesis of Congeners and Prodrugs Cushman, Mark S. / Purdue University
NIH 1987 N01 CM	Synthesis of Congeners and Prodrugs Cushman, Mark S. / Purdue University
NIH 1987 N01 CM	Synthesis of Congeners and Prodrugs Cushman, Mark S. / Purdue University
NIH 1986 N01 CM	Synthesis of Congeners and Prodrugs Cushman, Mark S. / Purdue University

Publications

Cushman, M; Nagarathnam, D; Gopal, D et al. (1991) Synthesis and evaluation of stilbene and dihydrostilbene derivatives as potential anticancer agents that inhibit tubulin polymerization. J Med Chem 34:2579-88

Cushman, M; Kanamathareddy, S; De Clercq, E et al. (1991) Synthesis and anti-HIV activities of low molecular weight aurintricarboxylic acid fragments and related compounds. J Med Chem 34:337-42

Cushman, M; Chinnasamy, P; Chakraborti, A K et al. (1990) Synthesis of [beta-(4-pyridyl-1-oxide)-L-alanine4]-angiotensin I as a potential suicide substrate for protein-tyrosine kinases. Int J Pept Protein Res 36:538-43

Comments

Be the first to comment on Mark Cushman's grant